Side-by-side financials for FATE and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FATE | ARGX |
|---|---|---|
| Market cap | - | $55.29 B |
| US-listed rank | - | #303 |
| Revenue (latest FY) | $6.65M | - |
| Net income (latest FY) | -$136.31M | - |
| Net margin | -2051.1% | - |
| SEC filings | 827 | 272 |
Full pages: FATE THERAPEUTICS INC and ARGENX SE, or browse the full rankings.